MedPath

A randomized double-blind controlled study of Shuhe Granules in treating heart and kidney deficiency and Qi and blood disharmony syndrome of chronic insomnia disorder

Not Applicable
Conditions
insomnia
Registration Number
ITMCTR2023000013
Lead Sponsor
Guangdong Provincial hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Aged 18-70

(2) In line with Western medicine chronic insomnia diagnostic standards

It is consistent with the diagnostic criteria of chronic insomnia in the new edition of International Classification of Sleep Disorders? formulated by the American Academy of Sleep Medicine

(3) Consistent with the indications of Shuhe granules:

Both of the following three

a. sleep difficulty factor score of Pittsburgh Sleep Quality Index =1
b. daytime function factor score of Pittsburgh Sleep Quality Index =1

c. Dizziness, palpitation, low menstrual volume, spontaneous sweating, fear of wind, cold limbs, white tongue, pale face, pale or reddish eyelids (symptoms =3/8).

None of the following cannot appear at the same time

a. The lower eyelid is completely red

b. Warm hands

c. Dry, stiff stool

d. Thick and greasy or dry and rough moss

e. Pulse ratio greater than 5.5

(4) Sign informed consent

Exclusion Criteria

1.Preparing to become pregnant or during pregnancy or lactation;
2. Secondary insomnia caused by physical disease. For example: local pain, restless leg syndrome, sleep apnea syndrome, acute and chronic heart failure, chronic obstructive pulmonary disease, acute and chronic bronchitis, etc.
3. Secondary insomnia caused by mental disease. For example: Affective disorders, anxiety disorder, depression, schizophrenia, and any other serious mental disorders.
4. A Patient health questionnaire-9 (PHQ-9) score of 15 or higher;
5. A Generalized Anxiety Scale (GAD-7) score of 15 or higher
6. Use of medicine to treatment sleeping disorders in the past two week.
7.Participants in clinical trials of other drugs in the past 30 days;

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insomnia Severity Index;
Secondary Outcome Measures
NameTimeMethod
Pittsburgh Sleep Quality Index;Patient health questionnaire-9;polysomnography;Fatigue Severity Scale;Traditional Chinese Medicine Questionnaire of Quality of life on Insomnia disease;Generalized Anxiety Scale-7;
© Copyright 2025. All Rights Reserved by MedPath